PLEXXIKON ENGINEERING DRUGS FOR PERSONALIZED MEDICINE Trademark

Trademark Overview

On Friday, June 23, 2017, a trademark application was filed for PLEXXIKON ENGINEERING DRUGS FOR PERSONALIZED MEDICINE with the United States Patent and Trademark Office. The USPTO has given the PLEXXIKON ENGINEERING DRUGS FOR PERSONALIZED MEDICINE trademark a serial number of 87502884. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 15, 2021. This trademark is owned by Plexxikon Inc.. The PLEXXIKON ENGINEERING DRUGS FOR PERSONALIZED MEDICINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, diabetes, and central nervous system, autoimmune, bone, metabolic, and blood disorders
plexxikon engineering drugs for personalized medicine

General Information

Serial Number87502884
Word MarkPLEXXIKON ENGINEERING DRUGS FOR PERSONALIZED MEDICINE
Filing DateFriday, June 23, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 15, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 14, 2017

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"ENGINEERING DRUGS FOR PERSONALIZED MEDICINE"
Description of MarkThe mark consists of word PLEXXIKON followed by four circles connected by short lines in a manner of a molecular model, inside of a large circle, with ENGINEERING DRUGS FOR PERSONALIZED MEDICINE words stacked underneath.
Goods and ServicesPharmaceutical preparations for the treatment of cancer, diabetes, and central nervous system, autoimmune, bone, metabolic, and blood disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 30, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePlexxikon Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94710
Party NamePlexxikon Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94710

Trademark Events

Event DateEvent Description
Tuesday, February 16, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 15, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 20, 2020EXTENSION 5 GRANTED
Wednesday, July 8, 2020EXTENSION 5 FILED
Wednesday, July 8, 2020TEAS EXTENSION RECEIVED
Wednesday, February 5, 2020CORRECTED NOA E-MAILED
Tuesday, February 4, 2020DIVISIONAL PROCESSING COMPLETE
Monday, January 6, 2020DIVISIONAL REQUEST RECEIVED
Monday, February 3, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 6, 2020TEAS REQUEST TO DIVIDE RECEIVED
Saturday, January 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 2, 2020EXTENSION 4 GRANTED
Thursday, January 2, 2020EXTENSION 4 FILED
Thursday, January 2, 2020TEAS EXTENSION RECEIVED
Wednesday, July 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 1, 2019EXTENSION 3 GRANTED
Monday, July 1, 2019EXTENSION 3 FILED
Monday, July 1, 2019TEAS EXTENSION RECEIVED
Tuesday, January 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 4, 2019EXTENSION 2 GRANTED
Friday, January 4, 2019EXTENSION 2 FILED
Friday, January 4, 2019TEAS EXTENSION RECEIVED
Tuesday, July 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 6, 2018EXTENSION 1 GRANTED
Friday, July 6, 2018EXTENSION 1 FILED
Friday, July 6, 2018TEAS EXTENSION RECEIVED
Tuesday, January 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 25, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 9, 2017ASSIGNED TO LIE
Friday, September 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 22, 2017EXAMINER'S AMENDMENT ENTERED
Friday, September 22, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 22, 2017EXAMINERS AMENDMENT E-MAILED
Friday, September 22, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, September 21, 2017ASSIGNED TO EXAMINER
Saturday, July 1, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, June 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 27, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

medicine personalized drugs engineering plexxikon bone autoimmune metabolic blood disorders system nervous treatment preparations cancer